Concepedia

Antonio Antela

AA

Statistics

Publications

5

Citations

1.1K

H-Index

5

Active since

1997

Affiliations

Siriraj Hospital(Current)

Antonio Antela is an author at Siriraj Hospital specializing in antiretroviral therapy, infectious diseases, and antiviral pharmacology.

Publications per year

1997–2017

5

Publications

5

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Sharon Walmsley, Antonio Antela, Nathan Clumeck et al. · New England Journal of Medicine · 2013 · 878 citations · Full text

, , +17

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

Estebán Martínez, María Larrousse, Josep M. Llibre et al. · AIDS · 2010 · 192 citations

, , +17

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

Pedro Cahn, Richard Kaplan, Paul E. Sax et al. · The Lancet HIV · 2017 · 35 citations · Full text

, , +15

Risk Factors for Development of Tuberculosis after Isoniazid Chemoprophylaxis in Human Immunodeficiency Virus--Infected Patients

José L. Casado, Santiago Moreno, Jesús Fortün et al. · Clinical Infectious Diseases · 2002 · 22 citations · Full text

, , +16

Acute mediastinitis due toRhodococcus equi in a patient with human immunodeficiency virus infection

José L. Casado, Antonio Antela, Joel Aldahir Cedeño Sánchez et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1997 · 12 citations

, , +10

1–5 of 5